评估单细胞-淋巴细胞比率,慢性病不同阶段的模式变化,风险和进展
Mumuni Alade Amisu1, Sotubo Sotomiwa2, Adegboyega Kayode3
1Department of Medicine, Nephrology Unit, Ikeja, Nigeria.
The Nigerian postgraduate medical journal
|October 27, 2025
概括
单细胞淋巴细胞比率 (MLR) 是慢性病 (CKD) 的一个有价值的炎症标志物. 增加的MLR与慢性病患者的功能恶化和疾病进展有很强的相关性.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 生物标志物发现发现
背景情况:
- 慢性病 (CKD) 的管理是昂贵和复杂的,需要具有成本效益的标记物.
- 单细胞淋巴细胞比率 (MLR) 作为CKD慢性系统性炎症的替代品.
- 升高的MLR表明CKD患者的炎症和免疫功能障碍增加.
研究的目的:
- 调查MLR和CKD阶段的进展之间的相关性.
- 评估MLR作为CKD严重程度的潜在指标.
主要方法:
- 一项涉及尼日利亚拉各斯300名CKD患者的横截面研究.
- 结核病的分期由估计的膜过率 (eGFR) 确定,使用病饮食修改 (MDRD) 公式.
- 从全血细胞计结果计算的MLR;使用SPSS分析的数据 (P <0.05显著性).
主要成果:
- 该研究包括300名CKD患者,平均年龄为58.5岁 (1.6:1男女比).
- 平均的MLR为0.44 (±0.14). 平均的MLR是0.44 (±0.14). 平均的MLR是0.44 (±0.14). 平均的MLR是0.44 (±0.14). 平均的MLR是0.44 (±0.14).
- 在CKD阶段和MLR之间发现了强烈的正相关性 (r = 0.763,P = 0.001). 与透析患者相比,CKD第二和第三阶段的患者在第四个MLR四分位数中的可能性增加了27.4倍.
结论:
- 升高的MLR与CKD所有阶段的功能下降显著相关.
- 现在,MLR已经成为一种与CKD进展相关的强有力的炎症标志物.
- 这一发现支持MLR在监测CKD严重程度和炎症方面的实用性.
相关概念视频
01:25Chronic Kidney Disease I: Introduction
556
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
556
01:28Chronic Kidney Disease III: Interprofessional Care
333
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
333
01:24Chronic Kidney Disease II: Clinical Manifestations
543
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
543
01:18Chronic Kidney Disease IV: Nursing Management
312
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
312
01:17Factors Affecting Renal Clearance: Renal Impairment
415
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
415
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
185
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
185